Alterity Therapeutics Limited (ASX:ATH)
0.0140
+0.0020 (16.67%)
Aug 29, 2025, 4:10 PM AEST
Alterity Therapeutics Employees
Alterity Therapeutics had 10 employees as of June 30, 2024. The number of employees decreased by 1 or -9.09% compared to the previous year.
Employees
10
Change (1Y)
-1
Growth (1Y)
-9.09%
Revenue / Employee
372.45K AUD
Profits / Employee
-1.98M AUD
Market Cap
110.50M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 10 | -1 | -9.09% |
Jun 30, 2023 | 11 | -1 | -8.33% |
Jun 30, 2022 | 12 | 1 | 9.09% |
Jun 30, 2021 | 11 | -1 | -8.33% |
Jun 30, 2020 | 12 | -2 | -14.29% |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
CSL Limited | 29,904 |
Pro Medicus | 132 |
Cochlear | 5,500 |
Sonic Healthcare | 42,000 |
Ramsay Health Care | 90,000 |
Telix Pharmaceuticals | 234 |
Ansell | 15,000 |
Mesoblast | 73 |
Alterity Therapeutics News
- 4 weeks ago - Appendix 4C – Q4 FY25 Quarterly Cash Flow Report - GlobeNewsWire
- 4 weeks ago - Alterity Therapeutics Reports Positive Topline Data from Open-Label Phase 2 Clinical Trial of ATH434 in Multiple System Atrophy - GlobeNewsWire
- 5 weeks ago - Alterity Therapeutics Announces Publication on Novel MRI Endpoint from the bioMUSE Natural History Study - GlobeNewsWire
- 2 months ago - Alterity Therapeutics to Provide Corporate Update in Fireside Chat - GlobeNewsWire
- 3 months ago - Alterity Therapeutics Prominently Featured at the International MSA Congress - GlobeNewsWire
- 4 months ago - Alterity Therapeutics Announces Multiple Oral and Poster Presentations to be Featured at the International MSA Congress - GlobeNewsWire
- 4 months ago - Alterity Therapeutics Granted U.S. FDA Fast Track Designation for ATH434 to Treat Multiple System Atrophy - GlobeNewsWire
- 4 months ago - Appendix 4C – Q3 FY25 Quarterly Cash Flow Report - GlobeNewsWire